Literature DB >> 26210985

Prevalence, predictors, and outcomes of cardiorenal syndrome in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry.

Ahmad Kaddourah1, Stuart L Goldstein1,2, Steven E Lipshultz3,4, James D Wilkinson3, Lynn A Sleeper5, Minmin Lu5, Steven D Colan6, Jeffrey A Towbin2, Scott I Aydin7, Joseph Rossano8, Melanie D Everitt9, Jeffrey G Gossett10, Paolo Rusconi4, Paul F Kantor11, Rakesh K Singh12, John L Jefferies13,14.   

Abstract

BACKGROUND: The association of cardiorenal syndrome (CRS) with mortality in children with dilated cardiomyopathy (DCM) is unknown.
METHODS: With a modified Schwartz formula, we estimated glomerular filtration rates (eGFR) for children ≥1 year of age with DCM enrolled in the Pediatric Cardiomyopathy Registry at the time of DCM diagnosis and annually thereafter. CRS was defined as an eGFR of <90 mL/min/1.73 m(2). Children with and without CRS were compared on survival and serum creatinine concentrations (SCr). The association between eGFR and echocardiographic measures was assessed with linear mixed-effects regression models.
RESULTS: Of 285 eligible children with DCM diagnosed at ≥1 year of age, 93 were evaluable. CRS was identified in 57 of these 93 children (61.3%). Mean (standard deviation) eGFR was 62.0 (22.6) mL/min/1.73 m(2) for children with CRS and 108.0 (14.0) for those without (P < 0.001); median SCr concentrations were 0.9 and 0.5 mg/dL, respectively (P < 0.001). The mortality hazard ratio of children with CRS versus those with no CRS was 2.4 (95% confidence interval 0.8-7.4). eGFR was positively correlated with measures of left ventricular function and negatively correlated with age.
CONCLUSIONS: CRS in children newly diagnosed with DCM may be associated with higher 5-year mortality. Children with DCM, especially those with impaired left ventricular function, should be monitored for renal disease.

Entities:  

Keywords:  Cardiomyopathy; Cardiorenal syndrome; Chronic kidney disease; Heart failure; Pediatrics

Mesh:

Year:  2015        PMID: 26210985      PMCID: PMC4626312          DOI: 10.1007/s00467-015-3165-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  40 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Design and implementation of the North American Pediatric Cardiomyopathy Registry.

Authors:  M A Grenier; S K Osganian; G F Cox; J A Towbin; S D Colan; P R Lurie; L A Sleeper; E J Orav; S E Lipshultz
Journal:  Am Heart J       Date:  2000-02       Impact factor: 4.749

3.  Why multidisciplinary clinics should be the standard for treating chronic kidney disease.

Authors:  Guido Filler; Steven E Lipshultz
Journal:  Pediatr Nephrol       Date:  2012-07-04       Impact factor: 3.714

4.  Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children.

Authors:  H Finney; D J Newman; H Thakkar; J M Fell; C P Price
Journal:  Arch Dis Child       Date:  2000-01       Impact factor: 3.791

Review 5.  Kidney-heart interactions: epidemiology, pathogenesis, and treatment.

Authors:  Tomas Berl; William Henrich
Journal:  Clin J Am Soc Nephrol       Date:  2005-12-22       Impact factor: 8.237

Review 6.  Cardio-renal syndrome type 2: epidemiology, pathophysiology, and treatment.

Authors:  Preeti Jois; Alexandre Mebazaa
Journal:  Semin Nephrol       Date:  2012-01       Impact factor: 5.299

Review 7.  Cardiorenal [corrected] syndrome: an emerging problem in pediatric critical care.

Authors:  John Lynn Jefferies; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2012-07-18       Impact factor: 3.714

8.  The incidence of pediatric cardiomyopathy in two regions of the United States.

Authors:  Steven E Lipshultz; Lynn A Sleeper; Jeffrey A Towbin; April M Lowe; E John Orav; Gerald F Cox; Paul R Lurie; Kristina L McCoy; Melissa A McDonald; Jane E Messere; Steven D Colan
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

9.  National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification.

Authors:  Ronald J Hogg; Susan Furth; Kevin V Lemley; Ronald Portman; George J Schwartz; Josef Coresh; Ethan Balk; Joseph Lau; Adeera Levin; Annamaria T Kausz; Garabed Eknoyan; Andrew S Levey
Journal:  Pediatrics       Date:  2003-06       Impact factor: 7.124

Review 10.  Target organ cross talk in cardiorenal syndrome: animal models.

Authors:  Lennart G Bongartz; Branko Braam; Carlo A Gaillard; Maarten J Cramer; Roel Goldschmeding; Marianne C Verhaar; Pieter A Doevendans; Jaap A Joles
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-22
View more
  4 in total

1.  Is it time for a multi-specialty approach to cardio-renal dysfunction in children with cyanotic congenital heart disease?

Authors:  Tanya Holt; Guido Filler
Journal:  Pediatr Nephrol       Date:  2017-10-02       Impact factor: 3.714

2.  Hemodynamic Predictors of Renal Function After Pediatric Left Ventricular Assist Device Implantation.

Authors:  Chiu-Yu Chen; Maria E Montez-Rath; Lindsay J May; Katsuhide Maeda; Seth A Hollander; David N Rosenthal; Catherine D Krawczeski; Scott M Sutherland
Journal:  ASAIO J       Date:  2021-12-01       Impact factor: 2.872

3.  Long-term outcomes of simultaneous heart and kidney transplantation in pediatric recipients.

Authors:  Patricia L Weng; Juan Carlos Alejos; Nancy Halnon; Qiuheng Zhang; Elaine F Reed; Eileen Tsai Chambers
Journal:  Pediatr Transplant       Date:  2017-07-20

4.  Novel urinary tubular injury markers reveal an evidence of underlying kidney injury in children with reduced left ventricular systolic function: a pilot study.

Authors:  Ahmad Kaddourah; Stuart L Goldstein; Rajit Basu; Edwards J Nehus; Tara C Terrell; Lori Brunner; Michael R Bennett; Christopher Haffner; John L Jefferies
Journal:  Pediatr Nephrol       Date:  2016-05-02       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.